Taken together, these data show that the inhibitory effects of Obatoclax on the late steps of autophagy are independent of those on cell survival, and suggest that Atg7 might have autophagy-independent functions that are necessary for the ability of Obatoclax to kill thyroid cancer cells. Here, ATG7 is linked to thyroid gland carcinoma.